TickerFacts.

Enveric Biosciences, Inc. (ENVB): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$31.76M
Year ended 2019-12-31
+2.8%
3-year compound annual growth
$38.36M2015-12-31: $13.39M2016-12-31: $29.22M2017-12-31: $38.36M2018-12-31: $34.01M2019-12-31: $31.76M$31.76M
2015-12-31 Cost of Revenue (USD) 2019-12-31
Period endedCost of RevenueChange YoYSource filing
2019-12-31$31.76M-6.6%2020-08-12, From 2019-01-01
2018-12-31$34.01M-11.3%2020-08-12, From 2018-01-01
2017-12-31$38.36M+31.3%2019-03-26, From 2017-01-01
2016-12-31$29.22Mn/c2018-04-02, From 2016-01-01
2015-12-31$13.39Mn/a2017-04-04, From 2015-01-01